Characteristic | Number of patients (n) | Preoperative plasma big ET-1 levels (pg/ml) | P value |
---|---|---|---|
Gender | Â | Â | Â |
   Male | 78 | 4.62 ± 0.72 | 0.285 |
   Female | 30 | 4.85 ± 0.63 |  |
Age, y | Â | Â | Â |
   ≤ 60 yrs | 41 | 4.67 ± 0.55 | 0.876 |
   >60 yrs | 67 | 4.72 ± 0.86 |  |
Smoking | Â | Â | Â |
   Light-smoker | 42 | 4.78 ± 0.39 | 0.386 |
   Non-smoker | 66 | 4.65 ± 0.64 |  |
Drinking | Â | Â | Â |
   Light-drinker | 35 | 4.73 ± 0.27 | 0.674 |
   Non-drinker | 73 | 4.68 ± 0.50 |  |
Site of tumor | Â | Â | Â |
   upper | 12 | 4.75 ± 0.91 | 0.763 |
   Middle | 57 | 4.70 ± 0.57 |  |
   Lower | 39 | 4.69 ± 0.83 |  |
Tumor differenciation | Â | Â | Â |
   Well | 30 | 4.61 ± 0.54 | 0.354 |
   Moderate | 48 | 4.64 ± 0.68 |  |
   Poor | 30 | 4.88 ± 0.47 |  |
Tumor class | Â | Â | Â |
   T1 | 33 | 4.42 ± 0.61 | 0.001 |
   T2 | 38 | 4.60 ± 0.34 |  |
   T3 | 37 | 5.01 ± 0.84 |  |
   T4 | 0 | 0 |  |
Lymph node metastasis | Â | Â | Â |
   N0 | 63 | 4.45 ± 0.59 | <0.001 |
   N1 | 45 | 5.06 ± 0.63 |  |
Stage | Â | Â | Â |
   I | 28 | 4.41 ± 0.52 | 0.003 |
   II | 48 | 4.68 ± 0.76 |  |
   III | 32 | 5.25 ± 0.82 |  |
   IV | 0 | 0 |  |